Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Allarity Therapeutics Inc ALLR

Healthcare Biotechnology
Allarity Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The Company is focused on development of stenoparib, a poly-ADP-ribose polymerase/Tankyrase inhibitor for advanced ovarian cancer patients, using its DRP companion diagnostic for patient selection in the ongoing phase 2 clinical trial, NCT03878849. It has in-licensed the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ALLR)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

GlobeNewswire November 18, 2024

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights

GlobeNewswire November 14, 2024

ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile November 12, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. Inc. of Class Action Lawsuit and Upcoming Deadlines - ALLR

Accesswire November 12, 2024

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Business Wire November 12, 2024

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire November 12, 2024

FINAL REMINDER ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Allarity Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit!

Accesswire November 12, 2024

ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile November 11, 2024

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Accesswire November 11, 2024
View More News ››

Opinion & Analysis (NDAQ:ALLR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALLR)

ALLR.....30 : 1 RS effective today

On watch and Halted pending RS Last at $0.1135
Iseneschal - September 11, 2024

ALLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC

JUST IN: $ALLR ALLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc...
whytestocks - July 28, 2024

ALLR...Meeting Postponed

Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting 2024-07-26 06:00 ET - News Release Boston (July 26...
Iseneschal - July 26, 2024

Investigation Into Allarity Therapeutics, Inc. (ALLR) Announ

BREAKING NEWS: $ALLR Investigation Into Allarity Therapeutics, Inc. (ALLR) Announced by Holzer & Holzer, LLCATLANTA, July 24, 2024...
whytestocks - July 24, 2024

ALLR.....more tricks this a.m....Volume ?

https://www.sec.gov/Archives/edgar/data/1860657/000121390024063581/ea020982201ex99-1_allarity.htm
Iseneschal - July 24, 2024

Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered |

News; $ALLR Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered | BenzingaAllarity Therapeutics Inc (NASDAQ:ALLR) shares are...
whytestocks - June 24, 2024
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp. is a Canadian mining company. The Company is engaged exploring and developing its lithium properties in ...
View More »